期刊文献+

1-(3-氟苯基)-2-(6-甲氧基-2-(1-(3,4,5-三甲氧基苯基)乙烯基)苯并呋喃-5-基)乙烯合成工艺优化及活性初探

Optimization in Synthesis Process and Preliminary Study on Activity of 1-(3-Fluorophenyl)-2-(6-methoxy-2-(1-(3,4,5-trimethoxyphenyl)vinyl)benzofuran-5-yl)ethylene
下载PDF
导出
摘要 以4-甲氧基水杨醛为原料、乙腈为溶剂,通过溴代、碘代、Rap-Stoermer偶联、Heck偶联4步反应合成了目标化合物1-(3-氟苯基)-2-(6-甲氧基-2-(1-(3,4,5-三甲氧基苯基)乙烯基)苯并呋喃-5-基)乙烯,通过单因素实验对关键步骤碘代反应条件进行了优化,通过^(1)HNMR、^(13)CNMR、MS对目标化合物的结构进行了表征,并对目标化合物的微管蛋白和PI3K双靶点抑制活性进行了初步研究。结果表明,碘代反应最佳条件为:以对甲苯磺酸一水合物为催化剂、反应温度25℃、反应时间10 h、碘代试剂用量n(4-甲氧基水杨醛)∶n(N-碘代丁二酰亚胺)为1∶1.0、溶剂用量n(4-甲氧基水杨醛)∶V(乙腈)为1∶3(mmol∶mL),在此条件下碘代反应产率为70.6%;通过分子对接验证了目标化合物具有双靶点抑制活性,其对微管蛋白的抑制活性高于对PI3K的抑制活性。 Using 4-methoxy salicylaldehyde as a raw material and acetonitrile as a solvent,we synthesized the target compound 1-(3-fluorophenyl)-2-(6-methoxy-2-(1-(3,4,5-trimethoxyphenyl)vinyl)benzofuran-5-yl)ethylene by a four-step reaction of bromination,iodination,Rap-Stoermer coupling,and Heck coupling.Moreover,we optimized the reaction conditions of the key step iodination by single-factor experiments,and characterized the structure of the target compound by ^(1)HNMR,^(13)CNMR,and MS.Furthermore,we preliminarily studied the double-target inhibitory activity of tubulin and PI3K.The results show that the optimal conditions of iodination reaction are obtained as follows:p-toluene sulfonate monohydrate as the catalyst,the reaction temperature of 25℃,the reaction time of 10 h,n(4-methoxy salicylaldehyde)∶n(N-iodo succinimide)of 1∶1.0,and n(4-methoxy salicylaldehyde)∶V(acetonitrile)of 1∶3(mmol∶mL).Under above conditions,the yield of iodination reaction is 70.6%.The double-target inhibitory activity of target compound is verified by molecular docking,indicating the inhibitory activity on tubulin is higher than that on PI3K.
作者 陈嘉媛 高祎婷 骈继鑫 包颖 杨康 CHEN Jiayuan;GAO Yiting;PIAN Jixin;BAO Ying;YANG Kang(School of Pharmacy,Xinjiang Second Medical College,Karamay 834000,China)
出处 《化学与生物工程》 CAS 北大核心 2024年第8期32-37,共6页 Chemistry & Bioengineering
基金 新疆维吾尔自治区自然科学基金地州科学基金项目(2021D01F40),新疆第二医学院科研基金面上项目(MS202301)。
关键词 4-甲氧基水杨醛 N-碘代丁二酰亚胺 化学合成 分子对接 4-methoxy salicylaldehyde N-iodo succinimide chemical synthesis molecular docking
  • 相关文献

参考文献3

二级参考文献39

  • 1Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin, 2010,60(5):277-300.
  • 2Jeremic B, Milicic B, Dagovic A, et al. Pretreatment clinical prognostic factors in patients with stage 1V non-small cell lung cancer (NSCLC) treated with chemotherapy. J Cancer Res Clin Oncol, 2003,129(2): 114-122.
  • 3Wakelee HA, Bernardo P, Johnson DH, et al. Changes in the natural history of nonsmall cell lung cancer (NSCLC)-comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990. Cancer, 2006,106(10):2208-2217.
  • 4Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc, 2008,83(5):584-594.
  • 5Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: updated 2003. J Clin Oncol, 2004,22(2):330-353.
  • 6Shepherd FA, Dancey J, Ramlau R, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol, 2000,18(10):2095-2103.
  • 7Idbaih A, Aimard J, Boisselier B, et al. Epidermal growth factor receptor mutations in lung cancer. J Neuropathol Appl Neurobiol, 2009,35(2):208-213.
  • 8Ettinger DS. Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancer. Oncologist, 2006,11(4): 358-373.
  • 9Sharma SV, Bell DW, Settleman J, et al. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer, 2007,7(3): 169-181.
  • 10Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science, 2004,304(5676): 1497-1500.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部